Moderna (NASDAQ:MRNA)
SEC filing history & article coverage
Transparent by design.
Announcments by Moderna (NASDAQ:MRNA) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Results of Operations and Financial Condition
Moderna raises 2026 outlook after 29% revenue growth and positive melanoma data
Departure/Election of Directors or Officers; Compensatory Arrangements; Regulation FD Disclosure
Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation; Unregistered Sales of Equity Securities; Other Events